NCT05804383View on ClinicalTrials.gov

A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease

PHASE1RecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions

Alzheimer's Disease

Interventions

DRUG

BMS-984923

Capsules

DRUG

Placebo

Capsules

Trial Locations (2)

53095

ACTIVE_NOT_RECRUITING

Spaulding Clinical Research, West Bend

06511

RECRUITING

Yale University, New Haven

Sponsors

Lead Sponsor

Allyx Therapeutics

All Listed Sponsors

collaborator

Yale University

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Allyx Therapeutics

INDUSTRY

NCT05804383 - A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter